GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three ...
Brooks Macdonald said on Tuesday that it has agreed to buy financial planning firm Lift for up to £45m. Lift is headquartered ...
Wall Street futures were in the green ahead of the bell on Tuesday amid heightened oil prices and rising bond yields.